4.3 Letter

Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19

Journal

JOURNAL OF ADDICTION MEDICINE
Volume 15, Issue 5, Pages 439-440

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ADM.0000000000000786

Keywords

-

Funding

  1. U.S. Department of Veterans Affairs Veterans Integrated Service Network (VISN) 19
  2. VA Salt Lake City Health Care System (VASLCHCS)
  3. Vulnerable Veteran Innovative PACT (VIP) Initiative at the VASLCHCS
  4. Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA) at the University of Utah
  5. VA Health Services Research and Development (HSR&D) Quality Enhancement Research Initiative (QUERI) Partnered Evaluation Initiative
  6. VIP Initiative
  7. VISN 19/QUERI [PII 18-181, QUERI PII 19-321]
  8. VA [QUERI PEI 19-001]
  9. NIH NIDA [1UG1DA04944-01]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available